Dr. Renier Brentjens, MD, PhD from the Memorial Sloan Kettering Cancer Center, discusses the goal of armored CAR T-cells. He talks about how the researchers add additional genets to the …
The Goal of Armored CAR T Cells Read More
January 23, 2018 (Medical News Today) A group of researchers from Switzerland are now focused on improving ‘dendritic cell vaccines’, which are an important part of the immune system that …
‘Cross-dressing’ cells may improve cancer treatment Read More
Costs and Payer Questions A patient-specific and complicated manufacturing process such as CAR T is expected to be costly. The cost of the first CAR T cell therapy from Novartis …
CAR T-Cell Therapy HCP Guide – The Costs Involved in CAR T-Cell Therapy Read More
March 2, 2018 (Medical News Today) At present, the most common types of treatment for cancer – the leading cause of death – are chemotherapy, radiation, surgery, and hormonal therapy, …
The state of cancer: Are we close to a cure? Read More
November 28, 2017 (Discovery Medicine) Glioblastoma remains a major unmet medical need in the field of oncology. With less than 10% of patients surviving five years from initial diagnosis, it …
Immunotherapy for Glioblastoma: On the Sidelines or in the Game? Read More